Literature DB >> 8546211

Effects of CD11b/18 monoclonal antibody on rats with permanent middle cerebral artery occlusion.

J H Garcia1, K F Liu, M P Bree.   

Abstract

The progression of a lesion from ischemic injury to infarct, after the permanent occlusion of a middle cerebral artery, may be influenced by the influx of leukocytes into the ischemic territory. We aimed to evaluate the effectiveness of treating rats that had permanent middle cerebral artery occlusion with a single dose of an anti-CD11b/18 monoclonal antibody injected 1 hour after the arterial occlusion. To mimic the clinical situation of patients with ischemic strokes who may be treated within 1 hour of the ischemic event, the artery remained occluded. Forty-one adult Wistar rats had permanent middle cerebral artery occlusion, and one was subjected to a sham operation. One hour later, 22 rats received CD11b/18 monoclonal antibody and an additional 20 were injected either with a nonspecific antibody (n = 10) or a buffer solution (n = 10). Experiments were terminated at intervals ranging 12 to 96 hours after the arterial occlusion. Endpoints included neurological testing, daily evaluation of body weight, counts of white blood cells in the peripheral blood, measurement of the area of pallor in the ischemic hemisphere, counts of necrotic neurons, and counts of leukocytes sequestered in the ischemic hemisphere. In experiments terminated 12 hours after the arterial occlusion (n = 4), there were fewer necrotic neurons in the group treated with the CD11b/18 monoclonal antibody compared with the two controls (P < .05), but this difference was not reflected in the neurological scores. Numbers of necrotic neurons in experiments terminated > 12 hours later were not different among the three subgroups. White blood cell counts in peripheral blood were lower in animals with arterial occlusion injected with the monoclonal antibody CD11b/18 (P < .05); numbers of leukocytes sequestered in the ischemic hemisphere were not different in the three groups. Neither changes in body weight nor in the volume of the area of pallor were significantly different among the three groups.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546211      PMCID: PMC1861617     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

Review 1.  Leukocyte-endothelial cell interactions.

Authors:  R P McEver
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

Review 2.  Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.

Authors:  P M Kochanek; J M Hallenbeck
Journal:  Stroke       Date:  1992-09       Impact factor: 7.914

3.  Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons.

Authors:  E Mori; G J del Zoppo; J D Chambers; B R Copeland; K E Arfors
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

Review 4.  Endothelial-leukocyte adhesion molecules.

Authors:  M P Bevilacqua
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion.

Authors:  J Hill; T Lindsay; J Rusche; C R Valeri; D Shepro; H B Hechtman
Journal:  Surgery       Date:  1992-08       Impact factor: 3.982

6.  P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion.

Authors:  Y Okada; B R Copeland; E Mori; M M Tung; W S Thomas; G J del Zoppo
Journal:  Stroke       Date:  1994-01       Impact factor: 7.914

7.  Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.

Authors:  J H Garcia; Y Yoshida; H Chen; Y Li; Z G Zhang; J Lian; S Chen; M Chopp
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat.

Authors:  H Chen; M Chopp; R L Zhang; G Bodzin; Q Chen; J R Rusche; R F Todd
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

Review 9.  [Microcirculation of skeletal muscle after ischemia and reperfusion].

Authors:  M D Menger; K Messmer
Journal:  Wien Med Wochenschr       Date:  1993

10.  Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.

Authors:  G J del Zoppo; G W Schmid-Schönbein; E Mori; B R Copeland; C M Chang
Journal:  Stroke       Date:  1991-10       Impact factor: 7.914

View more
  10 in total

Review 1.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 2.  Cell adhesion molecules and ischemic stroke.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neurol Res       Date:  2008-10       Impact factor: 2.448

Review 3.  Brain-immune interactions in perinatal hypoxic-ischemic brain injury.

Authors:  Bo Li; Katherine Concepcion; Xianmei Meng; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2017-10-27       Impact factor: 11.685

4.  Brain dendritic cells in ischemic stroke: time course, activation state, and origin.

Authors:  Jennifer C Felger; Takato Abe; Ulrike W Kaunzner; Andres Gottfried-Blackmore; Judit Gal-Toth; Bruce S McEwen; Costantino Iadecola; Karen Bulloch
Journal:  Brain Behav Immun       Date:  2009-11-13       Impact factor: 7.217

Review 5.  Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke.

Authors:  Aldo Bonaventura; Luca Liberale; Alessandra Vecchié; Matteo Casula; Federico Carbone; Franco Dallegri; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

Review 6.  Cerebral ischemic damage in diabetes: an inflammatory perspective.

Authors:  Vibha Shukla; Akhalesh Kumar Shakya; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  J Neuroinflammation       Date:  2017-01-23       Impact factor: 8.322

Review 7.  Innate Immunity Cells and the Neurovascular Unit.

Authors:  Ivan Presta; Marco Vismara; Fabiana Novellino; Annalidia Donato; Paolo Zaffino; Elisabetta Scali; Krizia Caterina Pirrone; Maria Francesca Spadea; Natalia Malara; Giuseppe Donato
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

Review 8.  Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.

Authors:  Anamaria Jurcau; Aurel Simion
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 9.  Inflammatory responses in hypoxic ischemic encephalopathy.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

Review 10.  Anti-inflammatory treatments for stroke: from bench to bedside.

Authors:  Antoine Drieu; Damien Levard; Denis Vivien; Marina Rubio
Journal:  Ther Adv Neurol Disord       Date:  2018-07-30       Impact factor: 6.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.